Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana Federica Convit"'
Autor:
Jeismar M Carballo O, Teresa Gledhill, Yetsenia M De Gouveia, María A Duarte C, Ana Federica Convit, Eglys González-Marcano, Angie García, Diana Cecilia Gracia Ruiz
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
ConvitVax is a personalized vaccine for the treatment of breast cancer, composed of autologous tumor cells, bacillus Calmette-Guérin (BCG) and low concentrations of formalin. Previous pre-clinical studies show that this therapy induces a potent acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37791ee2feeed87007f456b0125333ad
http://europepmc.org/articles/PMC8209199
http://europepmc.org/articles/PMC8209199
Publikováno v:
Oncotarget
// Maria Jose Godoy-Calderon 1 , 2 , Eglys Gonzalez-Marcano 1 , 2 , Jeismar Carballo 2 and Ana Federica Convit 1 , 2 1 Unidad Experimental de Inmunoterapia, Fundacion Jacinto Convit, Caracas, Venezuela 2 Jacinto Convit World Organization, Inc., Palo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e036801bbf1417386ef487c665f1d47f
https://doi.org/10.18632/oncotarget.27283
https://doi.org/10.18632/oncotarget.27283
Publikováno v:
Cancer Immunology Research. 7:B112-B112
Immune checkpoint inhibitors have shown satisfactory results in different types of cancer, such as lung cancer and melanoma. However, in breast cancer their benefit as a stand-alone treatment have not been robust, suggesting the need of combined ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcd7e4ed6dbee058002582775c03b29d
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-b112
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-b112